What's Going On With Hims & Hers Stock Tuesday?

Hims & Hers Health, Inc. HIMS stock traded higher Tuesday despite initially dropping after the company reported first-quarter earnings.

What To Know: The company reported earnings per share of 20 cents, beating the consensus estimate of 12 cents. In addition, the company reported sales of $586.01 million, beating the consensus estimate of $538.20 million and representing a 111% year-over-year increase.

Hims reported that subscribers increased 38% year-over-year to 2.4 million.

“We’re starting 2025 with incredible momentum. Millions of people are turning to us for access to care that is personal, affordable, and has the potential to drive better outcomes,” said Andrew Dudum, co-founder and CEO.

Outlook: The company sees second-quarter sales from $530 million to $550 million, versus the consensus estimate of $564.56 million. For fiscal-year 2025, the company expects sales from $2.30 billion to $2.40 billion, versus the consensus estimate of $2.32 billion.

See Also: Cathie Wood Bucks Consensus, Predicts Economic Boom And Broad Bull Market: ‘The Opportunity Is Now’

HIMS Price Action: At the time of writing, Hims stock is trading 11.3% higher at $46.60, per data from Benzinga Pro.

Image: via Shutterstock